Assessment of the efficacy of an antimicrobial peptide in the context of cystic fibrosis airways
Antimicrobial peptides (AMPs) offer a promising alternative to control airway infections with multi-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), which commonly infects patients with cystic fibrosis (CF).However, the behavior of AMPs in the CF context has yet to be fully elucidated.CF airways produce large amounts